WuXi AppTec offers a range of services for pharmaceutical and biotechnology companies, including research and development.
WuXi evolved from low-cost contract research to originating 50% of clinical trial drugs, illustrating how offshoring production eventually offshores innovation — a cautionary tale for US pharma and tech supply chains.